Related Experiment Videos
Ocular effects of second generation oral hypoglycemic agents
J M Lightman1, J C Townsend, G J Selvin
1Department of Ophthalmology, University of California-Davis, Sacramento 95816.
Journal of the American Optometric Association
|November 1, 1989
Summary
Second-generation oral hypoglycemic agents, like glyburide and glipizide, can cause vision changes. These sulfonylureas may induce lens alterations and refractive shifts independent of blood sugar levels.
Area of Science:
- Ophthalmology
- Endocrinology
- Pharmacology
Background:
- Second-generation sulfonylureas (glyburide, glipizide) are common treatments for non-insulin dependent diabetes mellitus.
- These agents function as potent osmotic agents.
Observation:
- A case report details crystalline lens changes and refractive error shifts.
- These ocular changes occurred without concurrent variations in blood glucose levels.
Findings:
- Sulfonylureas can induce ocular side effects, including lens opacities and refractive shifts.
- The mechanism involves osmotic effects within the crystalline lens.
Implications:
- Ophthalmologists and endocrinologists should be aware of potential visual disturbances associated with these medications.
- Monitoring visual function may be necessary in patients using second-generation oral hypoglycemic agents.